North America Multimodal Imaging Market

North America Multimodal Imaging Market Size & Forecast:

• North America Multimodal Imaging Market Size 2025: USD 1.79 Billion
• North America Multimodal Imaging Market Size 2033: USD 2.708 Billion 
• North America Multimodal Imaging Market CAGR: 5.31%
• North America Multimodal Imaging Market Segments: By Type (PET/CT, PET/MRI, SPECT/CT, Hybrid Imaging, Optical Imaging, Others), By Application (Oncology, Cardiology, Neurology, Research, Diagnostics, Others), By End-User (Hospitals, Diagnostic Centers, Research Institutes, Clinics, Others), By Technology (Imaging Systems, Software, AI Imaging, Detectors, Radiotracers, Others). 

To learn more about this report,  Download Free Sample Report

North America Multimodal Imaging Market Summary: 

The North America Multimodal Imaging Market size is estimated at USD 1.79 Billion in 2025 and is anticipated to reach USD 2.708 Billion by 2033, growing at a CAGR of 5.31% from 2026 to 2033. The healthcare industry is showing increased demand for multimodal imaging systems which combine different imaging technologies to provide precise diagnostic results and treatment planning solutions. 

The combination of PET and CT and MRI technologies enables clinicians to obtain complete structural and functional data through a single scan which results in better operational performance and enhanced treatment results. The increasing incidence of chronic diseases which includes cancer and neurological disorders drives healthcare facilities to implement advanced medical systems. The healthcare market experiences growth because of ongoing technological advancements and the move toward precise medical treatments which hospitals and diagnostic facilities adopt.

The North America Multimodal Imaging Market experiences strong growth because of increased demand for tests that detect diseases early and provide tests which require only small body samples. Healthcare institutions are investing in hybrid imaging systems to reduce diagnostic errors and streamline workflows which ultimately lowers overall treatment costs. The region experiences consistent growth because of its supportive reimbursement policies and strong research funding throughout the area. The market will experience continuous progress and expanded medical uses because artificial intelligence and data analytics will become more integrated with imaging platforms.

What Has the Impact of Artificial Intelligence Been on the North America Multimodal Imaging Market?

Artificial intelligence is changing how North American multimodal imaging systems process and analyze imaging data. AI in North America multimodal imaging market applications enables faster and more accurate diagnostics by integrating machine learning algorithms with multimodal systems such as PET-CT and MRI. The development provides healthcare organizations with deeper clinical insights through enhanced market research and data analysis capabilities. 

The North America multimodal imaging market uses predictive analytics to help organizations identify market trends while they forecast demand patterns and create investment strategies with greater accuracy. Artificial intelligence integration into North America multimodal imaging market operations produces efficiency improvements throughout production processes and supply chain operations. Smart automation reduces manual intervention in imaging workflows which results in higher diagnostic throughput and lower diagnostic error rates. 

AI-powered tools optimize supply chain performance by improving inventory management while decreasing operational expenses. North American multimodal imaging market companies use these innovations to create personalized imaging solutions which help them build competitive advantages while they quickly develop new products. Artificial intelligence in North America multimodal imaging market ecosystems creates fresh growth possibilities while it transforms current industry practices.

Key Market Trends & Insights: 

• The United States controls the north america multimodal imaging market which is expected to reach 75% market share in 2025 because of its advanced healthcare systems. 
• Canada is the fastest-growing region which will achieve more than 7ÊGR until 2030 because of increased healthcare spending and growing need for diagnostic services. 
• North America multimodal imaging market analysis shows that PET-CT systems will provide 45% market share in 2025 because of their use in oncology imaging. 
• SPECT-CT systems maintain their second-largest market position because of their growing use in cardiology and neurology diagnostic procedures. 
• The segment of PET-MRI displays the most rapid growth which will continue until 2030 because of new developments in hybrid imaging systems. 
• Oncology functions as the primary field of application within the north america multimodal imaging market which needs over 50% market share to perform early cancer diagnosis and treatment assessment. 
• The field of neurology experiences its highest growth rate because of the rising number of neurodegenerative disorder cases and the need for accurate diagnostic tests. 
• The north america multimodal imaging market belongs to hospitals because they maintain advanced imaging systems and receive high patient volume. 
• The segment of diagnostic imaging centers shows the fastest growth rate because it offers both affordable and targeted imaging solutions. 

North America Multimodal Imaging Market Segmentation

By Type

The PET/CT systems will maintain their strong market position because of their ability to accurately diagnose oncology conditions and monitor treatment progress. PET/MRI systems will attract interest because they provide superior soft tissue imaging while minimizing radiation exposure. SPECT/CT technology will deliver accurate functional measurements for both cardiac and neurological imaging procedures. Healthcare facilities will adopt hybrid imaging solutions because they need to achieve better diagnostic results through simultaneous testing methods.

Research and specialized diagnostic fields will begin to adopt optical imaging together with some other imaging methods. The healthcare providers will require more integrated systems because they want to shorten scan durations while enhancing their patient results. The technology upgrades will bring improvements in both image quality and operational efficiency. The growth of all types will remain interconnected with the increasing prevalence of chronic illnesses and the growing need for diagnostic services.

To learn more about this report,  Download Free Sample Report

By Application

Healthcare needs for early cancer diagnosis and treatment monitoring will lead to oncology becoming the dominant medical specialty. The field of cardiology will experience growth because of rising heart disease rates and the need for advanced diagnostic imaging technologies. The field of neurology will experience steady growth because of increasing cases of Alzheimer’s disease together with other brain disorders. Medical imaging requires diagnostic tools which doctors need for both their standard and their complex imaging examinations.

Research use will increase with growing investment in clinical trials and medical innovation. The need for precise disease identification through imaging will drive growth in the application. The use of advanced imaging systems will enhance both treatment preparation and patient monitoring. The expansion of applications will increase because more people understand better healthcare services.

By End-User

The hospital system will experience growth because of its robust infrastructure and ability to handle high patient numbers which demands advanced imaging technology. The diagnostic center market will experience rapid expansion because cost-effective imaging solutions are becoming more popular. Research institutes will contribute to scientific progress through their ongoing research activities and their need for advanced imaging equipment. The clinics will implement diagnostic systems through a step-by-step process which will lead to their development of expert medical services.

Healthcare facility investment will enable complete system implementation for all user groups. Healthcare facilities will implement new systems because they need to achieve quicker results with fewer mistakes. All facilities will continue to prioritize better service quality through their operational activities. The demand for precise and swift imaging solutions will create a need for enhanced development processes.

By Technology

The development of imaging systems will continue because of hardware improvements and better system integration capabilities. Data processing and image analysis will be primarily handled by software solutions. The field of AI imaging will experience rapid growth because automation and diagnostic capabilities continue to improve. The use of detectors will improve both image quality and the operational effectiveness of the system.

Radiotracers will remain essential for functional imaging and disease detection. The development of technology will enable scientists to achieve results that are both faster and more dependable. The implementation of advanced tools will create better operational processes while decreasing the need for physical work. The adoption of technology throughout the organization will drive both market growth and future innovations.

What are the Main Challenges for the North America Multimodal Imaging Market Growth? 

The north america multimodal imaging market faces several technical and operational challenges that limit growth potential. The combination of PET and CT and MRI systems results in complex systems that demonstrate inconsistent performance. Healthcare providers experience operational difficulties because their systems require extensive maintenance and their software programs do not work together. 

Equipment availability and system expansion capabilities in the north america multimodal imaging market face ongoing challenges from supply chain interruptions and shortages of essential components. The north america multimodal imaging market faces major obstacles because of manufacturing and commercialization barriers. The development of advanced imaging systems requires significant financial investment as well as specialized engineering capabilities and adherence to stringent regulatory standards including quality certifications. 

The product approval process together with clinical validation requirements creates delays that extend time-to-market for new products. The combination of these factors increases total expenses while hindering manufacturers from achieving efficient operational expansion throughout the north america multimodal imaging market.

The industry faces significant adoption challenges because both multimodal imaging infrastructure and trained professionals remain limited. The high costs associated with installing and running equipment force smaller healthcare facilities to delay their technology adoption. The market suffers from limitations because of funding shortfalls and healthcare access disparities. The north america multimodal imaging market encounters growth obstacles that prevent its development in multiple healthcare environments.

Country Insights

United States: Advanced healthcare systems and strong investment in imaging technologies and early disease detection methods create conditions which United States will use to lead regional economic growth. Market position will improve because major industry players exist and AI-enabled imaging solutions are being adopted at a fast pace. Hospital infrastructure systems will continue to receive upgrades which will enable the organization to grow and develop new ideas.

Canada: Canada will experience consistent economic expansion because healthcare expenditures are increasing and people are becoming more knowledgeable about modern diagnostic methods. The government will implement programs which will enhance access to medical imaging services and this will result in provincial adoption of these services. The market development will receive support from chronic disease cases because healthcare facilities will need more precise imaging solutions which meet their operational needs.

Rest of North America: The healthcare sector in North America will experience slow growth because medical facilities improve and people become more interested in accurate diagnostic methods. Healthcare systems will increase their investment in modern imaging technologies because they want to provide better service. The growth of private healthcare providers will promote service adoption but the expansion rate will be slower than what developed areas experience.

Recent Development News

In March 2026, Lantheus got FDA approval for an advanced prostate cancer imaging formulation: Lantheus Holdings received FDA approval for its upgraded PSMA PET imaging agent “Pylarify TruVu", improving production efficiency and distribution of prostate cancer scans. The development enhances nuclear imaging accessibility and supports higher-resolution diagnostic workflows across US oncology centres.

Source: https://www.reuters.com

In March 2026, Butterfly Network received FDA clearance for an AI ultrasound pregnancy tool:  Butterfly Network secured U.S. FDA clearance for its AI-powered ultrasound system designed to estimate gestational age in pregnancy. The innovation uses deep-learning models trained on millions of scans, enabling rapid, low-cost imaging in emergency and rural care settings across the U.S., strengthening AI-driven multimodal imaging adoption.

Source: https://www.reuters.com

How Can New Companies Establish a Strong Foothold in the North America Multimodal Imaging Market?

New entrants can establish strong market positions in the North America multimodal imaging sector through their dedication to meeting specific clinical requirements and filling existing diagnostic deficiencies. Startups can create their unique identity by focusing on oncology imaging and neurological diagnostics as their primary research areas. The integration of AI-based analytics with multimodal systems will lead to enhanced operational performance through improved precision and streamlined processes. The specialized solution development process which matches current industry patterns will help businesses achieve rapid market expansion.

The north america multimodal imaging market requires technology differentiation through machine learning integration with cloud-based imaging systems. New companies can address key pain points such as high operational costs and slow image processing by offering scalable and cost-efficient platforms. The establishment of strategic partnerships with hospitals and research centers and imaging labs will help products achieve validation and market acceptance. Emerging companies use collaboration to build credibility and enhance their ability to distribute products.

Subtle Medical and Aidoc are emerging players who show how innovation can help businesses gain market share in the North America multimodal imaging industry. The companies develop AI-based imaging solutions which enhance imaging results and provide immediate diagnostic information to medical professionals. Continuous investment in R&D and user-friendly software design will further strengthen positioning. The healthcare solutions which match actual healthcare requirements will enable new market entrants to achieve success in their competitive environments.

Key North America Multimodal Imaging Market Company Insights

The major players will keep their dominant market positions through their ongoing product improvements and their extensive distribution networks. The companies will develop advanced imaging systems which provide higher accuracy and faster processing capabilities. The organization will use its strong financial resources to fund both research projects and business development initiatives. The company will maintain its market dominance because of its established relationships with hospitals and diagnostic centers.

The introduction of AI imaging solutions and intelligent automation systems will give companies a competitive edge through their innovative development methods. The organization will develop new solutions which enhance workflow productivity while decreasing the duration required for scanning procedures. The system performance will benefit from improved software integration together with enhanced data analytics capabilities. The organization will maintain its competitive edge through ongoing enhancements of its imaging resolution.

Healthcare providers and research institutes will establish strategic partnerships which will enable the organization to increase its market presence and drive product usage. The company will strengthen its distribution network through its expansion into new areas and establishment of new facility networks. The companies will achieve their product testing goals and regulatory permission processes more quickly through their cooperative efforts. The joint ventures will enable organizations to exchange technological resources while achieving savings through shared expenses.

Healthcare facilities with budget constraints will find competitive pricing strategies to be the primary factor which draws them to our services. The companies will provide solutions which create value through better performance to their customers. The brand will strengthen its market position through product differentiation which includes technological advancements and dedicated customer service. The organization will gain more customers through its ability to deliver affordable services which can be customized according to customer needs.

Company List

• Siemens Healthineers
• GE Healthcare
• Philips
• Canon Medical
• Hitachi
• Shimadzu
• Fujifilm
• Agfa-Gevaert
• Bruker
• Mediso
• United Imaging
• NeuroLogica
• Digirad
• Positron
• Toshiba

What are the Key Use-Cases Driving the Growth of the North America Multimodal Imaging Market?

The north america multimodal imaging market exists because advanced clinical use-cases in oncology require combined imaging systems which include PET-CT for precise tumor detection and treatment monitoring. The hospitals depend on these systems because they help hospitals achieve better diagnostic results while decreasing the need for additional scans, which benefits their patients. The rising cancer rates together with the requirement for early cancer detection are driving hospitals to implement these diagnostic tools. This use-case remains a core growth engine within the North America multimodal imaging market.

The north america multimodal imaging market benefits from cardiology and neurology applications which are growing their market share. Multimodal imaging provides complete heart condition and brain disorder visualization which improves decision-making speed and accuracy. Integrated imaging insights improve stroke diagnosis and Alzheimer's assessment. The demand for non-invasive diagnostic tools which provide accurate results is driving growth in these sectors.

Multimodal imaging serves research institutions and pharmaceutical companies through its application in drug development and clinical trials. The applications enable precise evaluation of treatment response together with tracking disease progression. The research sector uses this technology to generate additional revenue while driving innovation in the north america multimodal imaging market.

North America Multimodal Imaging Market Report Segmentation

By Type

• PET/CT
• PET/MRI
• SPECT/CT
• Hybrid Imaging
• Optical Imaging
• Others

By Application

• Oncology
• Cardiology
• Neurology
• Research
• Diagnostics
• Others

By End-User

• Hospitals
• Diagnostic Centers
• Research Institutes
• Clinics
• Others

By Technology

• Imaging Systems
• Software
• AI Imaging
• Detectors
• Radiotracers
• Others